Acadia Healthcare (NASDAQ:ACHC) Hits New 1-Year High – Here’s Why

Acadia Healthcare Company, Inc. (NASDAQ:ACHC)’s stock price hit a new 52-week high during trading on Wednesday . The stock traded as high as $30.71 and last traded at $30.5560, with a volume of 370087 shares changing hands. The stock had previously closed at $29.53.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on ACHC shares. Zacks Research raised shares of Acadia Healthcare from a “strong sell” rating to a “hold” rating in a report on Thursday, March 5th. TD Cowen boosted their target price on Acadia Healthcare from $24.00 to $30.00 and gave the stock a “buy” rating in a research report on Tuesday, April 28th. Cantor Fitzgerald upped their target price on Acadia Healthcare from $20.00 to $30.00 and gave the stock a “neutral” rating in a research note on Friday, May 1st. UBS Group boosted their price objective on Acadia Healthcare from $27.00 to $31.00 and gave the stock a “buy” rating in a report on Friday, April 17th. Finally, Jefferies Financial Group upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their target price for the company from $24.50 to $30.00 in a research report on Wednesday, June 3rd. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have given a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $26.85.

Acadia Healthcare Price Performance

The stock has a market capitalization of $2.93 billion, a P/E ratio of -2.61, a price-to-earnings-growth ratio of 10.42 and a beta of 0.64. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.71 and a current ratio of 1.71. The firm has a 50-day moving average price of $25.62 and a 200 day moving average price of $21.16.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.09. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The business had revenue of $828.80 million during the quarter, compared to analyst estimates of $823.51 million. During the same quarter in the prior year, the firm earned $0.40 earnings per share. Acadia Healthcare’s revenue for the quarter was up 7.6% on a year-over-year basis. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. On average, analysts expect that Acadia Healthcare Company, Inc. will post 1.5 EPS for the current year.

Hedge Funds Weigh In On Acadia Healthcare

Large investors have recently added to or reduced their stakes in the business. Goldman Sachs Group Inc. boosted its position in Acadia Healthcare by 417.8% during the fourth quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock valued at $67,099,000 after buying an additional 3,815,471 shares during the period. Jefferies Financial Group Inc. bought a new stake in shares of Acadia Healthcare in the 4th quarter valued at about $47,960,000. Wellington Management Group LLP boosted its holdings in Acadia Healthcare by 24.9% during the 4th quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock valued at $167,077,000 after acquiring an additional 2,350,760 shares during the period. Vaughan Nelson Investment Management L.P. purchased a new stake in Acadia Healthcare during the 1st quarter valued at about $43,017,000. Finally, Invenomic Capital Management LP grew its position in Acadia Healthcare by 71.0% during the 4th quarter. Invenomic Capital Management LP now owns 3,312,043 shares of the company’s stock worth $46,998,000 after acquiring an additional 1,375,647 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.